This CME/CE activity informs clinicians on how they can show leadership in how language can destigmatize the disease of addiction. It is focused on using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.
- Words Matter - Terms to Use and Avoid When Talking About Addiction
- Jointly provided by Postgraduate Institute for Medicine and National Institute on Drug Abuse
- Release date: July 15, 2021
- Expiration date: September 15, 2023
- Estimated time to complete activity: 45 minutes
- Mechanism for the learner to contact PIM
This activity is intended for physicians, physician assistants, pharmacists, registered nurses, nurse practitioners/other APRNs, and dentists engaged in the care of patients with substance use disorders.
After completing this activity, the participant should be better able to:
- Explain the effects of stigmatizing language on patients with addiction.
- Compare common terminology and assess which terms should be used or avoided and why.
- Integrate person-first, non-stigmatizing language into everyday practice.
- Identify terms to use and terms to avoid when speaking to patients about addiction.
- Faculty and Disclosure of Conflicts of Interest
Faculty Name/Professional Credential Title and Affiliation Michelle Corbin, MBA NIDAMED Coordinator
National Institute on Drug Abuse
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose.
The following planners and others have nothing to disclose Michelle Corbin from the National Institute on Drug Abuse, Melinda Campopiano, Erika Capinguian, Susan Hayashi, and Laura Nolan from JBS International, Inc.
- Method of Participation and Request for Credit
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
- Go to cmeuniversity.com
- Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- Type in 16349 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
- Click on the activity title when it appears
- Choose the type of credit you desire
- Complete the Post-test with a passing score of 75% or better
- Complete the online Evaluation
- Receive an immediate CE Certificate to download and/or print for your files
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better (if applicable) and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
If you have questions regarding the certification of this activity, please contact PIM via email at email@example.com.
Joint Accreditation StatementImage
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the National Institute on Drug Abuse. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
- Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-21-2678-H01-P)
Type of Activity: Knowledge
Hardware/Software Requirements (Required for Internet-based ACPE activities only)
Include minimum hardware, software, internet connectivity and connection speed requirements for accessing the internet-based activity.
Policy on Privacy and Confidentiality (Required for Internet-based ACPE activities only)
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Continuing Dental Education
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Postgraduate Institute for Medicine designates this activity for 0.75 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Computer System Requirements
Content is accessible regardless of internet browser. However, the Google Chrome browser often performs best.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.